These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2388474)

  • 21. c-abl function in normal and chronic myelogenous leukemia hematopoiesis: in vitro studies with antisense oligomers.
    Rosti V; Bergamaschi G; Ponchio L; Cazzola M
    Leukemia; 1992 Jan; 6(1):1-7. PubMed ID: 1736009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic cytotoxic effect of azidothymidine and recombinant interferon alpha on normal human bone marrow progenitor cells.
    Berman E; Duigou-Osterndorf R; Krown SE; Fanucchi MP; Chou J; Hirsch MS; Clarkson BD; Chou TC
    Blood; 1989 Sep; 74(4):1281-6. PubMed ID: 2765664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-interferon: differential suppression of colony growth from human erythroid, myeloid, and megakaryocytic hematopoietic progenitor cells.
    Mazur EM; Richtsmeier WJ; South K
    J Interferon Res; 1986 Jun; 6(3):199-206. PubMed ID: 3745985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro growth of human fetal CD34+ cells in the presence of various combinations of recombinant cytokines under serum-free culture conditions.
    Zauli G; Vitale M; Visani G; Marchisio M; Milani D; Capitani S
    Br J Haematol; 1994 Mar; 86(3):461-7. PubMed ID: 7519034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.
    Gordon MY; Marley SB; Lewis JL; Davidson RJ; Nguyen DX; Grand FH; Amos TA; Goldman JM
    J Clin Invest; 1998 Aug; 102(4):710-5. PubMed ID: 9710439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cells.
    Beran M; O'Brien S; Andersson B; McCredie KB; Gutterman JU
    Hematol Pathol; 1988; 2(2):65-71. PubMed ID: 3143710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of responsiveness of chronic myelogenous leukemia granulocyte-macrophage colony-forming cells to growth regulation following in vivo treatment with recombinant gamma-interferon.
    Pelus LM; Vadhan-Raj S
    Am J Hematol; 1988 May; 28(1):21-6. PubMed ID: 3130750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
    Einat M; Lishner M; Amiel A; Nagler A; Yarkorli S; Rudi A; Kashman Y; Markel D; Fabian I
    Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged suppression of myeloid progenitor cell numbers after stopping interferon treatment for CML may necessitate delay in harvesting marrow cells for autografting.
    De Fabritiis P; Sandrelli A; Meloni G; Alimena G; Montefusco E; Lo Coco F; De Felice L; Mandelli F
    Bone Marrow Transplant; 1990 Oct; 6(4):247-51. PubMed ID: 2085699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of chronic myelogenous leukemia colony growth by interleukin-4.
    Estrov Z; Markowitz AB; Kurzrock R; Wetzler M; Kantarjian HM; Ferrajoli A; Gutterman JU; Talpaz M
    Leukemia; 1993 Feb; 7(2):214-20. PubMed ID: 8426475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-alpha and bcr-abl antisense oligodeoxynucleotides in combination enhance the antileukemic effect and the adherence of CML progenitors to preformed stroma.
    Bellucci R; Sala R; De Propris MS; Cordone I; de Fabritiis P
    Leuk Lymphoma; 1999 Nov; 35(5-6):471-81. PubMed ID: 10609784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies of interferon as a regulator of hematopoietic cell proliferation.
    Raefsky EL; Platanias LC; Zoumbos NC; Young NS
    J Immunol; 1985 Oct; 135(4):2507-12. PubMed ID: 2411798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restoration of nonclonal hematopoiesis in chronic myelogenous leukemia with interferon alpha.
    Egert G; Kanz L; Löhr GW; Fauser AA
    Blut; 1990 May; 60(5):282-6. PubMed ID: 2350591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of recombinant interferons on the clonogenic growth of leukemic cells and normal hemopoietic progenitors.
    Hosoi T; Ozawa K; Urabe A; Takaku F
    Int J Cell Cloning; 1985 Sep; 3(5):304-12. PubMed ID: 3930631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent antileukemic activity of the novel agents norsegoline and dibezine.
    Einat M; Nagler A; Lishner M; Amiel A; Yarkoni S; Rudi A; Gellerman G; Kashman Y; Fabian I
    Clin Cancer Res; 1995 Aug; 1(8):823-9. PubMed ID: 9816051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon alfa-2c in chronic myelogenous leukemia (CML): hematologic, cytogenetic and molecular-genetic response of patients with chronic phase CML previously resistant to therapy with interferon gamma.
    Herrmann F; Jonas D; Helfrich SG; Lindemann A; Schleiermacher E; Mertelsmann R
    Blut; 1990 Oct; 61(4):226-31. PubMed ID: 2121299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro busulfan sensitivity of granulocyte-macrophage and erythroid progenitor cells in patients with chronic myelogenous leukemia.
    Kubota K; Preisler HD; Costanzo C; Miura Y
    Cancer Res; 1983 Dec; 43(12 Pt 1):6090-3. PubMed ID: 6580066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the antiproliferative properties of recombinant human IFN-alpha 2 and IFN-omega in human bone marrow culture.
    Tiefenthaler M; Geisen F; Schirmer M; Konwalinka G
    J Interferon Cytokine Res; 1997 Jun; 17(6):327-9. PubMed ID: 9197999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.